Background: In 2012, the Centers for Disease Control dropped the blood lead level (BLL) of concern to 5 mcg/dL due to recent evidence of neurocognitive impairment at low levels. According to the 2009-2010 National Health and Nutrition Examination Survey, over 1 million children ≤6 years old have BLL ≥5 mcg/ dL. Reduced public health resources and the housing crisis may have worsened the situation, with low prioritization of lead poisoning on the public health agenda and inadequate funding for remediation of low-income homes. Research Question: Does early childhood lead exposure negatively impact academic performance (AP) in mathematics, reading and science among Detroit schoolchildren in elementary and junior high schools? Methods: This is a retrospective cohort study of students in the Detroit public school system who had taken at least one of three Michigan Educational Assessment Program (MEAP) standardized tests in mathematics, reading and/or science in 2008, 2009 or 2010 and had their blood tested for lead from 0 to 6 years of age. There are four MEAP result categories: 1 (advanced), 2 (proficient), 3 (partially proficient) and 4 (not proficient). These were combined into two study groups: "less than proficient" (LP; categories 1 and 2) and "proficient or better" (categories 3 and 4). Blood lead surveillance data from the Detroit Department of Health involving children born between 1990 and 2008 were linked to MEAP scores by child name, gender and date of birth. Those who met these criteria totaled 21,281. Regression modeling of dichotomized MEAP scores and log-transformed BLL was performed. Multivariate logistic regression analysis controlled for confounding factors including grade level, gender, race, language, maternal education and SES. Results: A dose-response relationship was demonstrated with higher BLL associated with poorer MEAP scores (p < 0.001) through unadjusted analysis of variance testing. The differences in BLL between MEAP score category were found to be significant (p <0.05). Logistic regression revealed that BLL could predict the probability of being LP in all three MEAP subject areas (p <0.05). The probability of testing as LP rose as BLL increased to 10 mcg/dL. Multivariate logistic regression demonstrated increased odds ratios (OR) as BLL rose above 1 mcg/dL. Compared to students with BLL <1 mcg/dL, those with BLL of 1-5 mcg/dL, 6-10 mcg/dL and >10 mcg/ dL had OR of being LP in mathematics of 1.42 (CI=1.24, 1.63), 2.00 (CI = 1.74, 2.30) and 2.40 (CI = 2.07, 2.77), respectively. There were similar OR for being LP in reading and science as well. Conclusion: After attempting to control for confounding variables, the authors found that early childhood lead exposure resulting in BLL even lower than 5 mcg/dL adversely affects AP. Critique: Within the confines of bias associated with the convenience samples extracted from the databases, the authors were limited to recorded demographic features without mention of other confounding exposures, such as tobacco. Also, SES was based on school lunch status, which was not a sufficiently refined surrogate since 80 % of subjects received a free school lunch. The MEAP results were not analyzed as a continuous variable, but pooled into only two categories.
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Finally, standardized tests have not been proven to be validated tools for assessing AP in students of lower SES. Implication for Toxicologists: Pediatric lead poisoning is a concerning environmental exposure that may be reemerging in urban centers in the USA due to dwindling public health funding. This study suggests that a BLL <5 mcg/dL negatively impacts AP. Prioritization of this problem, family education and patient advocacy is important for improved environmental justice. Background: Naltrexone is an FDA approved medication for the treatment of alcohol dependence. The subgroup of patients who suffer from both alcohol dependence and post-traumatic stress disorder (PTSD) are particularly challenging to treat as these conditions compound each other leading to increased impairment. Research Question: Is the combination of naltrexone and prolonged exposure therapy more effective in reducing percentage of days drinking (PDD) and PTSD symptoms compared to either intervention alone or placebo? Methods: Participants were enrolled in a single-blinded, randomized control study at the University of Pennsylvania over about an 8-year period. All participants completed an outpatient detoxification program prior to enrolling and received supportive therapy that included medication management and compliance enhancement techniques. In addition, participants received one of four combinations of interventions: naltrexone alone, prolonged exposure therapy alone, their combination, or pill placebo. Naltrexone was initially started at 50 mg/day and titrated up to the goal of 100 mg/day. Prolonged exposure therapy consisted of 12 weekly sessions followed by 6 biweekly sessions. The PDD was calculated using the Timeline Follow-Back Interview. PTSD symptom severity was calculated using the PTSD Symptom Severity Interview tool. Both outcomes were measured prior to treatment at post-treatment (week 24), and at 6 months after treatment discontinuation (week 52). Results: Over 1,200 patients were screened for the study. One hundred and sixty-five participants enrolled in the study. Of those enrolled, 32.1 % dropped out, resulting in 112 participants completing the study. Eighty-five percent of participants met criteria for compliance with medications and supportive counseling. Participants completed a mean of 6.18 (SD, 3.86) exposure therapy sessions of 18 proposed sessions. The naltrexone and exposure therapy group had the lowest PDD at 52 weeks (8.8 CI 3.3 to 14.3). Also, at 52 weeks, patients who received naltrexone (with or without exposure therapy) compared to those who received placebo had lower PDD (mean difference=7.93 %, p =0.008). All groups showed reduction in PTSD symptoms; however, there was no difference between those who received exposure therapy versus supportive therapy alone at 52 weeks. Conclusion : Naltrexone plus exposure therapy in patients with PTSD and alcohol dependence resulted in decreased PDD for up to 6 months after therapy. Critique: Although this was a well-done study with rigorous methodology that explored an important research topic, there were limitations. All participants were described as "treatmentseeking individuals" which may have introduced selection bias. The percentage of patients that adhered to the study protocols, specifically exposure therapy, and completed the entire study was low. Also, there was no true placebo arm, as all patients received supportive therapy. Finally, the authors did not record the total number of drinks, but PDD. Some subjects may have engaged in binge drinking that may have occurred on fewer days, but involved the same or an even higher amount of drinks. Implication for Toxicologists: Toxicologists should be knowledgeable about the treatment modalities for alcohol withdrawal and PTSD, as well as the increased risks associated with caring for patients with both comorbidities. Background: Small, concentrated laundry detergent packs were introduced in the USA in early 2012. There have been several case reports of severe toxicity associated with exploratory ingestion by young children, but there has not previously been a larger study comparing these exposures to traditional laundry detergents. Research Question: Are there differences in epidemiology, circumstance and clinical effects between laundry detergent packs and traditional laundry detergents? Methods: This is a retrospective study utilizing data collected by six poison centers in the state of Texas. Laundry detergent pack exposures reported from January 1 to June 30, 2012 were analyzed and compared to traditional laundry detergent exposures occurring from January 1 to December 31, 2011. To eliminate the problem of pack detergents being classified as traditional detergents, the earlier time frame was used for traditional laundry detergent exposures (pack detergents were not available until 2012). Patients were included if they were 5 years of age or younger and had no reported exposure to other substances. Age, sex, exposure route, management site, medical outcome and specific clinical effects were compared. Results: There were 187 laundry detergent pack (56 % male, mean age 1.9 years) and 452 traditional laundry detergent (57 % male, mean age 1.6 years) exposures that met inclusion criteria. Ingestion was the main route of exposure comprising 91 % of patients in both groups. There was a higher proportion of patients already at or en route to a health care facility in the laundry detergent pack group (21 vs 9 %), and they were more often referred by the poison center to a health care facility (24 vs 4 %). Patients with laundry detergent pack exposure had a higher proportion of known or suspected serious outcome (12.3 vs 2.4 %). There were statistically significant higher rates of clinical effects in the laundry detergent pack group compared to traditional detergents in vomiting (54.5 vs 17.0 %), coughing (11.2 vs 2.2 %), nausea (7.0 vs 2.7 %) and oral irritation (7.0 vs 2.2 %). Conclusion: The higher proportion of patients being managed or referred to a health care facility and the increased frequency of clinical effects and serious outcomes seen with laundry detergent packs support the assertion that they lead to greater toxicity than traditional laundry detergents. Higher concentrations, additional ingredients and different or quicker activation of detergent may be possible explanations for this observation.
Critique: This study retrospectively analyzes data from regional poison centers and is subject to several limitations. Reporting is voluntary, and cases included may not be typical of all exposures. Coding errors may have led to laundry detergent pack exposures being coded as traditional laundry detergent in the January 1 to June 30, 2012 period, and thus, those cases would not be included in the study. Determinations of medical outcome are typically based on objective criteria, but may be applied subjectively, and can vary amongst poison center staff. Exposures were often reported based on suspicion alone (i.e. a child found with a product's container) and not verified clinically. Implication for Toxicologists: Toxicologists should routinely ask about the formulation of the detergent, whether pack or traditional, and should recognize that laundry detergent packs potentially cause more serious toxicity. Background: Neurotoxic snakebite is a neglected disease of tropical countries resulting in weakness with respiratory failure; death is common. The mechanism of this neurotoxicity involves interruption of acetylcholine transmission at the neuromuscular junction. Neostigmine is used as an anticholinesterase agent to reverse neuromuscular blockade and reverses the effects of non-depolarizing agents. Intravenous neostigmine and edrophonium have been proposed to combat neurotoxic effects of snakebite when antivenoms are not available. Research Question: Using a mivacurium model of simulated neurotoxic snake envenomation, would neostigmine aerosol reverse paralysis in a human volunteer? Methods: A healthy 45-year-old man gave written informed consent and was monitored by two anesthesiologists during the experiment. A third physician collected data. Mivacurium, a non-depolarizing neuromuscular blocking agent, was administered to mimic neurotoxicity from a snakebite. Neuromuscular blockade was assessed by train of four (TOF) ratio at the left adductor pollicis. When the subject achieved level 3 TOF block and had significant oropharyngeal weakness, a single dose of 0.2 mg of IV glycopyrrolate was given to prevent bradycardia. Then, 27.6 mg (0.37 mg/kg) of neostigmine was administered intranasally using a primed atomizer. After 10 min, the mivacurium infusion was stopped and neuromuscular function was allowed to return spontaneously. Results: During administration of mivacurium, the subject exhibited weakness consistent with paralysis from neurotoxic envenomation. He demonstrated difficulty swallowing, tongue weakness, inability to flex the neck, and signs of respiratory distress. Intranasal neostigmine quickly reversed these effects (visual acuity, difficulty swallowing, head flexion, and peak flow). Conclusion: Intranasal neostigmine successfully reversed simulated neurotoxic snakebite symptoms modeled by a continuous infusion of mivacurium. Intranasal or otherwise topically applied anticholinesterases could be delivered without advanced technical skill. Critique: This is a fascinating experiment in a human volunteer. It was, however, a simulation and not a model for a snake-derived neurotoxin. It is unclear if this is an adequate model to extrapolate to the field setting of snake envenomation. Based on the proposed mechanism, the use of anticholinesterases should only work on alpha (postsynaptic) neurotoxins. Nonetheless, this is a very interesting and entertaining article to read. Implication for Toxicologists: Aerosolized neostigmine may be an option in the setting of neurotoxic envenomation in remote areas or when antivenom is not available. Further study is required before this therapy is widely adopted, particularly in centers with good resources.
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